Department of Internal Medicine, Ito Hospital, Tokyo, Japan.
Department of Surgery, Ito Hospital, Tokyo, Japan.
Eur Thyroid J. 2024 Oct 14;13(5). doi: 10.1530/ETJ-24-0128. Print 2024 Oct 1.
There are few reports of subacute thyroiditis (SAT) during pregnancy. This study aimed to clarify the clinical characteristics of SAT in pregnant patients.
Seven patients diagnosed with SAT during pregnancy at our institution from January 2004 to December 2021 were identified, and their clinical findings were retrospectively examined. At SAT diagnosis, the median age was 34 (range: 31-42) years, the median duration of pregnancy was 5 (4-24) weeks, and all patients had neck pain but no fever. On laboratory examination, median (range) free thyroxine, free triiodothyronine, and C-reactive protein levels were 2.66 (1.14-7.77) ng/dL, 7.1 (3.3-16.1) pg/mL, and 2.22 (0.42-5.79) mg/dL, respectively, and all patients had a hypoechoic lesion of the thyroid gland. Three patients (43%) were treated with steroids, and three patients (43%) received replacement therapy with levothyroxine for hypothyroidism following destructive thyroiditis. There were no pregnancy complications in any of the cases. These seven patients (pregnancy group) were compared with 217 non-pregnant female patients (non-pregnancy group) aged 31 to 42 years who were diagnosed with SAT at our institution from 2016 to 2019. The frequency of body temperatures above 37°C was lower in the pregnancy group than in the non-pregnancy group (0% vs 65%).
Patients who develop SAT during pregnancy may have less fever than non-pregnant patients with SAT. There were no pregnancy complications in the pregnancy group in this study. This suggests that adverse pregnancy outcomes may be avoided by the appropriate management of SAT, including hypothyroidism after destructive thyroiditis.
妊娠期间发生亚急性甲状腺炎(SAT)的报道较少。本研究旨在阐明妊娠患者 SAT 的临床特征。
本研究回顾性分析了 2004 年 1 月至 2021 年 12 月期间我院收治的 7 例妊娠合并 SAT 患者的临床资料。SAT 诊断时,患者的中位年龄为 34 岁(范围:31-42 岁),中位妊娠时间为 5 周(范围:4-24 周),所有患者均有颈痛但无发热。实验室检查显示,游离甲状腺素、游离三碘甲状腺原氨酸和 C 反应蛋白的中位数(范围)分别为 2.66(1.14-7.77)ng/dL、7.1(3.3-16.1)pg/mL 和 2.22(0.42-5.79)mg/dL,所有患者甲状腺均有低回声病变。3 例(43%)患者接受了类固醇治疗,3 例(43%)患者因破坏性甲状腺炎引起的甲状腺功能减退接受了左甲状腺素替代治疗。所有患者均无妊娠并发症。这 7 例患者(妊娠组)与 2016 年至 2019 年期间在我院诊断为 SAT 的 217 例年龄为 31 至 42 岁的非妊娠女性患者(非妊娠组)进行了比较。妊娠组体温高于 37°C 的频率低于非妊娠组(0% vs 65%)。
与非妊娠 SAT 患者相比,妊娠期间发生 SAT 的患者发热的频率可能较低。在本研究中,妊娠组无妊娠并发症。这表明通过适当的 SAT 管理(包括破坏性甲状腺炎后的甲状腺功能减退),可能避免不良妊娠结局。